Skip to main content
. 2021 Feb 8;162(9):2376–2385. doi: 10.1097/j.pain.0000000000002223

Table 1.

Clinical and demographic features of the study groups.

MIG group HC group P
N 24 19
Age (y) 33.0 ± 8.1 29.5±9.3 F1,41 1.773; P = 0.190
Female sex 22 (88.0%) 15 (78.9%) χ2 df 1 0.416; P = 0.416
Preventive therapy 15 (65.2%)
Migraine duration (y) 17.4 ± 9.7
Migraine days per month 8.8 ± 2.0
Days with intake of acute drugs per month 7.7 ± 1.9

MIG group: subjects with episodic migraine; HC group: healthy controls.

HC, healthy controls; MIG, migraine.